Gavin Lewis | Senior Vice President, Head of Value and Access
Novartis

Gavin originally was an undergraduate in Economics and Politics, before working for the Scottish Government as an Economist in the Health Department. After obtaining an MSc in Health Economics from York University, he joined the Pharmaceutical industry for Roche in the UK where he worked for over 10 years developing and leading their Health Economics and Pricing department. He has experience in leading over 50 Health Technology appraisals with NICE, SMC and also prepared Roche’s response to the Value Based Pricing consultation and contributed to the development of the NICE Guide to Methods for Technology Appraisal. Gavin left the UK to start a new role for Roche as Head of Pricing and Market Access for Region Europe, where he has developed a new team with responsibilities for strategic pricing, payer marketing and real world evidence for Europe. At AstraZeneca Gavin led the Global Oncology Market Access team supporting the launch of several new brands. Gavin joined Amgen as Vice President for Value, Access and Policy in 2017; leading access strategy, government affairs and price management for Region Europe, before being promoted to Global Head of Market Access for Amgen in 2021. In 2024 Gavin moved to Novartis to lead their Value and Access team for International Markets, leading a team of over 200 access professionals responsible for pricing and reimbursement across over 100 markets